Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 400 participants.
Also called NCT07298473
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 400 participants
- Registry
-
NCT07298473
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Australia, Belgium, Czechia, France, Switzerland
- Registry status
- Recruiting
Technical summary
Registry record NCT07298473. Allocation not applicable; no masking; primary purpose treatment. Start 2026-04-08 (actual); primary completion 2028-03-29 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
- Acronym
- Conquer-AF
- Condition
- Atrial Fibrillation (AF)
- Condition
- Persistent Atrial Fibrillation
- Condition
- Paroxysmal Atrial Fibrillation (PAF)
- Intervention (Device)
- Sphere-9 Catheter Ablation
- Lead sponsor
- Medtronic Cardiac Ablation Solutions
Record details
- Record id
cardio:ct-nct07298473- Content hash
1d43aad0292e4d9c87b618fada63478a38a9e26dbce727b68c55dd83d1a5b751